Stefan K.F. Schwabe
2016
In 2016, Stefan K.F. Schwabe earned a total compensation of $1.2M as Executive Vice President of Research and Development, Chief Medical Officer at Supernus Pharmaceuticals, a 23% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $159,000 |
---|---|
Option Awards | $649,000 |
Salary | $366,583 |
Other | $41,082 |
Total | $1,215,665 |
Schwabe received $649K in option awards, accounting for 53% of the total pay in 2016.
Schwabe also received $159K in non-equity incentive plan, $366.6K in salary and $41.1K in other compensation.
Rankings
In 2016, Stefan K.F. Schwabe's compensation ranked 7,314th out of 14,075 executives tracked by ExecPay. In other words, Schwabe earned more than 48.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,314 | 48th |
Manufacturing | 2,759 | 50th |
Chemicals And Allied Products | 902 | 52nd |
Drugs | 701 | 54th |
Pharmaceutical Preparations | 558 | 53rd |
Schwabe's colleagues
We found four more compensation records of executives who worked with Stefan K.F. Schwabe at Supernus Pharmaceuticals in 2016.